Fingerprint
Dive into the research topics of 'Namodenoson in advanced hepatocellular carcinoma and child–pugh B cirrhosis: Randomized placebo-controlled clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Namodenoson in advanced hepatocellular carcinoma and child–pugh B cirrhosis: Randomized placebo-controlled clinical trial
Salomon M. Stemmer, Nebojsa S. Manojlovic, Mihai Vasile Marinca, Petar Petrov, Nelly Cherciu, Doina Ganea, Tudor Eliade Ciuleanu, Ioana Adriana Pusca, Muhammad Shaalan Beg, William T. Purcell, Adina Emilia Croitoru, Rumyana Nedyalkova Ilieva, Sladjana Natošević, Amedeia Lavinir Nita, Dimitar Nikolaev Kalev, Zivit Harpaz, Motti Farbstein, Michael H. Silverman, David Bristol, Inbal Itzhak
*Corresponding author for this work
- Rabin Medical Center Israel
- Military Medical Academy
- Institutul Regional de Oncologie Iasi—Sectia Oncologie Medical
- EOOD
- Clinica Onco-Life
- Sf. Ioan Cel Nou County Clinical Emergency Hospital
- Iuliu Hatieganu University of Medicine and Pharmacy
- S.C. Pelican Impex S.R.
- University of Texas Southwestern Medical Center
- University of Colorado Anschutz Medical Campus
- Fundeni Clinical Institute
- Multiprofile Hospital for Active Treatment Central Onco Hospital OOD
- Zdravstveni Centar Kladovo
- County Hospital Prahova
- University Hospital St. Marina
- Can-Fite BioPharma
Research output: Contribution to journal › Article › peer-review
31
Scopus
citations